173 related articles for article (PubMed ID: 38199429)
1. New immunotherapy approaches as the most effective treatment for uveal melanoma.
Eteghadi A; Ebrahimi M; Keshel SH
Crit Rev Oncol Hematol; 2024 Feb; 194():104260. PubMed ID: 38199429
[TBL] [Abstract][Full Text] [Related]
2. Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.
Goh AY; Layton CJ
Clin Exp Ophthalmol; 2016 Aug; 44(6):509-19. PubMed ID: 26601795
[TBL] [Abstract][Full Text] [Related]
3. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
[TBL] [Abstract][Full Text] [Related]
4. Recent approaches for the treatment of uveal melanoma: Opportunities and challenges.
Khan SA; Almalki WH; Arora S; Kesharwani P
Crit Rev Oncol Hematol; 2024 Jan; 193():104218. PubMed ID: 38040071
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances and Challenges in Uveal Melanoma Immunotherapy.
Fu Y; Xiao W; Mao Y
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804863
[TBL] [Abstract][Full Text] [Related]
6. Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma.
Al Balushi K; Al Hadhrami A; Balushi HA; Al Lawati A; Das S
Curr Drug Targets; 2024; 25(3):149-157. PubMed ID: 38115619
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in uveal melanoma treatment.
Álvarez-Rodríguez B; Latorre A; Posch C; Somoza Á
Med Res Rev; 2017 Nov; 37(6):1350-1372. PubMed ID: 28759124
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Uveal Melanoma.
Shoushtari AN; Carvajal RD
Cancer Treat Res; 2016; 167():281-93. PubMed ID: 26601868
[TBL] [Abstract][Full Text] [Related]
9. [What else can we do for uveal melanoma].
Li B; Xu XL
Zhonghua Yan Ke Za Zhi; 2009 Apr; 45(4):289-92. PubMed ID: 19575957
[TBL] [Abstract][Full Text] [Related]
10. Update on Metastatic Uveal Melanoma: Progress and Challenges.
Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for Uveal Melanoma - Current Knowledge and Perspectives.
Kaštelan S; Antunica AG; Oresković LB; Pelčić G; Kasun E; Hat K
Curr Med Chem; 2020; 27(8):1350-1366. PubMed ID: 31272342
[TBL] [Abstract][Full Text] [Related]
12. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract][Full Text] [Related]
13. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2018 Sep; 136(9):981-986. PubMed ID: 29955797
[TBL] [Abstract][Full Text] [Related]
14. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
15. The biology of uveal melanoma.
Amaro A; Gangemi R; Piaggio F; Angelini G; Barisione G; Ferrini S; Pfeffer U
Cancer Metastasis Rev; 2017 Mar; 36(1):109-140. PubMed ID: 28229253
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-proteasome system-targeted therapy for uveal melanoma: what is the evidence?
Zhao CX; Zeng CM; Wang K; He QJ; Yang B; Zhou FF; Zhu H
Acta Pharmacol Sin; 2021 Feb; 42(2):179-188. PubMed ID: 32601365
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort.
Lamas NJ; Lassalle S; Martel A; Nahon-Estève S; Macocco A; Zahaf K; Lalvee S; Fayada J; Lespinet-Fabre V; Bordone O; Pedeutour F; Baillif S; Hofman P
Pathology; 2023 Dec; 55(7):929-944. PubMed ID: 37863710
[TBL] [Abstract][Full Text] [Related]
18. Development of new therapeutic options for the treatment of uveal melanoma.
Wang JZ; Lin V; Toumi E; Wang K; Zhu H; Conway RM; Madigan MC; Murray M; Cherepanoff S; Zhou F; Shu W
FEBS J; 2021 Nov; 288(21):6226-6249. PubMed ID: 33838075
[TBL] [Abstract][Full Text] [Related]
19. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma.
Zhou J; Liu S; Wang Y; Dai W; Zou H; Wang S; Zhang J; Pan J
Mol Cancer; 2019 Nov; 18(1):159. PubMed ID: 31718679
[TBL] [Abstract][Full Text] [Related]
20. Uveal melanoma pathobiology: Metastasis to the liver.
Bustamante P; Piquet L; Landreville S; Burnier JV
Semin Cancer Biol; 2021 Jun; 71():65-85. PubMed ID: 32450140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
